By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
Jun 24, 2019/CPG
Guidelines on assessing and managing urinary incontinence and pelvic organ prolapse in women aged 18 and over.
May 1, 2020/CPG
Recommendations, updated in 2020, from the American Association of Clinical Endocrinologists and American College of Endocrinology on the diagnosis, evaluation, and treatment of postmenopausal osteoporosis for endocrinologists, physicians, regulatory bodies, health-related organizations, and interested
Jun 3, 2015/Policies & Bylaws
House position: Describes the designation of individuals with intellectual disabilities and developmental disabilities, or both, as a medically under-served population.
Oct 4, 2023/Policies & Bylaws
House position: APTA's support for primacy of jurisdictional statues and regulations over policies or rules of third-party payers.
APTA member engagement groups include councils, networks, and societies that help members connect with each other to share information and advance the profession.
Jan 25, 2021/Resource
Clear communication is a prerequisite to providing responsible care, ensuring patient safety, and optimizing outcomes.
Apr 16, 2020/Article
In a Facebook Live event, experts from physical therapy, psychology, and the Pan American Health Organization discussed the impact of COVID-19 on mental health and how physical therapists play an important role in the recovery of patients' mental and physical health.
Apr 15, 2022/Statement
APTA maintains that "physical therapy," whether provided in person or virtually, is performed or directed by licensed physical therapists.
Mar 31, 2015/CPG
The objective of the guideline is to delineate optimal diagnostic and therapeutic approaches to congenital muscular dystrophy (CMD) through a systematic review and analysis of available literature.
Jul 28, 2015/CPG
Recommendations for the evaluation, diagnosis, prognostication, and treatment of facioscapulohumeral muscular dystrophy (FSHD) from a systematic review and analysis of the evidence.